CN113121394B - Preparation method of phenoxyacetic acid derivative - Google Patents
Preparation method of phenoxyacetic acid derivative Download PDFInfo
- Publication number
- CN113121394B CN113121394B CN201911395193.4A CN201911395193A CN113121394B CN 113121394 B CN113121394 B CN 113121394B CN 201911395193 A CN201911395193 A CN 201911395193A CN 113121394 B CN113121394 B CN 113121394B
- Authority
- CN
- China
- Prior art keywords
- preparation
- reaction
- gft
- dimethyl
- methylthio
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 44
- LCPDWSOZIOUXRV-UHFFFAOYSA-N phenoxyacetic acid Chemical class OC(=O)COC1=CC=CC=C1 LCPDWSOZIOUXRV-UHFFFAOYSA-N 0.000 title claims abstract description 9
- 238000006243 chemical reaction Methods 0.000 claims abstract description 55
- XXSPGBOGLXKMDU-UHFFFAOYSA-N 2-bromo-2-methylpropanoic acid Chemical compound CC(C)(Br)C(O)=O XXSPGBOGLXKMDU-UHFFFAOYSA-N 0.000 claims abstract description 18
- 239000003513 alkali Substances 0.000 claims abstract description 5
- 238000006555 catalytic reaction Methods 0.000 claims abstract description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 42
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical group [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 24
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 16
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 15
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 claims description 14
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 12
- 239000002585 base Substances 0.000 claims description 12
- 239000002904 solvent Substances 0.000 claims description 11
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 10
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 9
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 7
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 4
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims description 3
- VSTXCZGEEVFJES-UHFFFAOYSA-N 1-cycloundecyl-1,5-diazacycloundec-5-ene Chemical compound C1CCCCCC(CCCC1)N1CCCCCC=NCCC1 VSTXCZGEEVFJES-UHFFFAOYSA-N 0.000 claims description 3
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 claims description 3
- 229910000024 caesium carbonate Inorganic materials 0.000 claims description 3
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 claims description 3
- 238000009413 insulation Methods 0.000 claims description 2
- -1 phenoxyacetic acid compound Chemical class 0.000 claims description 2
- 238000004321 preservation Methods 0.000 claims description 2
- 238000000034 method Methods 0.000 abstract description 13
- 239000003153 chemical reaction reagent Substances 0.000 abstract description 6
- 230000035484 reaction time Effects 0.000 abstract description 6
- PHRSDLZWVTXEOY-RUDMXATFSA-N (e)-3-(4-hydroxy-3,5-dimethylphenyl)-1-(4-methylsulfanylphenyl)prop-2-en-1-one Chemical compound C1=CC(SC)=CC=C1C(=O)\C=C\C1=CC(C)=C(O)C(C)=C1 PHRSDLZWVTXEOY-RUDMXATFSA-N 0.000 abstract description 4
- 239000002253 acid Substances 0.000 abstract description 4
- 230000008569 process Effects 0.000 abstract description 4
- 239000000463 material Substances 0.000 abstract description 3
- 238000001308 synthesis method Methods 0.000 abstract description 2
- 150000007513 acids Chemical class 0.000 abstract 1
- AFLFKFHDSCQHOL-IZZDOVSWSA-N gft505 Chemical compound C1=CC(SC)=CC=C1C(=O)\C=C\C1=CC(C)=C(OC(C)(C)C(O)=O)C(C)=C1 AFLFKFHDSCQHOL-IZZDOVSWSA-N 0.000 description 39
- 239000000243 solution Substances 0.000 description 28
- HTSGKJQDMSTCGS-UHFFFAOYSA-N 1,4-bis(4-chlorophenyl)-2-(4-methylphenyl)sulfonylbutane-1,4-dione Chemical compound C1=CC(C)=CC=C1S(=O)(=O)C(C(=O)C=1C=CC(Cl)=CC=1)CC(=O)C1=CC=C(Cl)C=C1 HTSGKJQDMSTCGS-UHFFFAOYSA-N 0.000 description 22
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 18
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 16
- 239000000047 product Substances 0.000 description 16
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 12
- 238000004809 thin layer chromatography Methods 0.000 description 10
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 8
- 230000000052 comparative effect Effects 0.000 description 8
- UYGBSRJODQHNLQ-UHFFFAOYSA-N 4-hydroxy-3,5-dimethylbenzaldehyde Chemical compound CC1=CC(C=O)=CC(C)=C1O UYGBSRJODQHNLQ-UHFFFAOYSA-N 0.000 description 6
- 229910000027 potassium carbonate Inorganic materials 0.000 description 6
- 238000012216 screening Methods 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 238000005804 alkylation reaction Methods 0.000 description 5
- 238000004440 column chromatography Methods 0.000 description 5
- 239000000543 intermediate Substances 0.000 description 5
- 239000012074 organic phase Substances 0.000 description 5
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 5
- JECUZQLBQKNEMW-UHFFFAOYSA-N 1-(4-methylsulfanylphenyl)ethanone Chemical compound CSC1=CC=C(C(C)=O)C=C1 JECUZQLBQKNEMW-UHFFFAOYSA-N 0.000 description 4
- AOIQHKQLNIFAMJ-UHFFFAOYSA-N bromo 2-methylpropanoate Chemical compound CC(C)C(=O)OBr AOIQHKQLNIFAMJ-UHFFFAOYSA-N 0.000 description 4
- 239000006227 byproduct Substances 0.000 description 4
- 239000005457 ice water Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 238000005160 1H NMR spectroscopy Methods 0.000 description 3
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical group [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 239000012295 chemical reaction liquid Substances 0.000 description 3
- 238000010511 deprotection reaction Methods 0.000 description 3
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 3
- 208000008338 non-alcoholic fatty liver disease Diseases 0.000 description 3
- 206010053219 non-alcoholic steatohepatitis Diseases 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 159000000000 sodium salts Chemical class 0.000 description 3
- IGVNJALYNQVQIT-UHFFFAOYSA-N tert-butyl 2-bromo-2-methylpropanoate Chemical compound CC(C)(C)OC(=O)C(C)(C)Br IGVNJALYNQVQIT-UHFFFAOYSA-N 0.000 description 3
- NXXYKOUNUYWIHA-UHFFFAOYSA-N 2,6-Dimethylphenol Chemical compound CC1=CC=CC(C)=C1O NXXYKOUNUYWIHA-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 102000003728 Peroxisome Proliferator-Activated Receptors Human genes 0.000 description 2
- 108090000029 Peroxisome Proliferator-Activated Receptors Proteins 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000002168 alkylating agent Substances 0.000 description 2
- 229940100198 alkylating agent Drugs 0.000 description 2
- 230000002152 alkylating effect Effects 0.000 description 2
- 230000029936 alkylation Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 150000007942 carboxylates Chemical class 0.000 description 2
- 239000003054 catalyst Substances 0.000 description 2
- 239000007806 chemical reaction intermediate Substances 0.000 description 2
- 238000012790 confirmation Methods 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 238000012805 post-processing Methods 0.000 description 2
- MFRIHAYPQRLWNB-UHFFFAOYSA-N sodium tert-butoxide Chemical compound [Na+].CC(C)(C)[O-] MFRIHAYPQRLWNB-UHFFFAOYSA-N 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- KTVKQTNGWVJHFL-UHFFFAOYSA-N 2-ethylchromen-4-one Chemical compound C1=CC=C2OC(CC)=CC(=O)C2=C1 KTVKQTNGWVJHFL-UHFFFAOYSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010022489 Insulin Resistance Diseases 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000002300 anti-fibrosis Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000007810 chemical reaction solvent Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 239000007859 condensation product Substances 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 1
- 229940043279 diisopropylamine Drugs 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 229940125542 dual agonist Drugs 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- DZGCGKFAPXFTNM-UHFFFAOYSA-N ethanol;hydron;chloride Chemical compound Cl.CCO DZGCGKFAPXFTNM-UHFFFAOYSA-N 0.000 description 1
- IOLQWGVDEFWYNP-UHFFFAOYSA-N ethyl 2-bromo-2-methylpropanoate Chemical compound CCOC(=O)C(C)(C)Br IOLQWGVDEFWYNP-UHFFFAOYSA-N 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- PGXWDLGWMQIXDT-UHFFFAOYSA-N methylsulfinylmethane;hydrate Chemical compound O.CS(C)=O PGXWDLGWMQIXDT-UHFFFAOYSA-N 0.000 description 1
- 238000006386 neutralization reaction Methods 0.000 description 1
- 238000005580 one pot reaction Methods 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000012071 phase Substances 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 238000007867 post-reaction treatment Methods 0.000 description 1
- 238000011112 process operation Methods 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000013341 scale-up Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- NESLWCLHZZISNB-UHFFFAOYSA-M sodium phenolate Chemical compound [Na+].[O-]C1=CC=CC=C1 NESLWCLHZZISNB-UHFFFAOYSA-M 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 125000003944 tolyl group Chemical group 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
- C07C319/14—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides
- C07C319/20—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides by reactions not involving the formation of sulfide groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
本发明公开了一种苯氧乙酸类衍生物的制备方法,该方法采用一步合成法,在碱催化下,将(E)‑2,6‑二甲基‑4‑(3‑(4‑(甲硫基)苯基)‑3‑氧代丙‑1‑烯‑1‑基)苯酚与2‑溴异丁酸反应即得。该制备方法简化了工艺路线,产物易分离纯化,操作简捷高效;同时避免大量使用强酸和溴代试剂,经济环保;此外,反应效率高,反应时间缩短,物料利用率高,产品总收率在75%以上,产品纯度达到99%以上。
The invention discloses a preparation method of phenoxyacetic acid derivatives. The method adopts a one-step synthesis method. Under alkali catalysis, (E)-2,6-dimethyl-4-(3-(4-( Methylthio) phenyl)-3-oxoprop-1-ene-1-yl) phenol reacts with 2-bromoisobutyric acid to obtain. The preparation method simplifies the process route, the product is easy to separate and purify, and the operation is simple and efficient; at the same time, a large number of strong acids and brominated reagents are avoided, which is economical and environmentally friendly; in addition, the reaction efficiency is high, the reaction time is shortened, the material utilization rate is high, and the total product yield is 75% or more, and the product purity reaches more than 99%.
Description
技术领域technical field
本发明涉及一种苯氧乙酸类衍生物的制备方法,具体涉及GFT-505的制备方法。The invention relates to a preparation method of phenoxyacetic acid derivatives, in particular to a preparation method of GFT-505.
背景技术Background technique
GFT-505结构如I所示,其具有苯氧乙酸类特征结构,是一类PPAR(过氧化物酶体增殖剂激活受体)α/δ双重激动剂。在临床前及临床研究中,GFT-505表现出增加脂肪酸氧化、改善胰岛素敏感性以及抗炎、抗纤维化等药效;此外其临床试验中耐受性良好,未发生严重的不良反应。GFT-505可以通过多种机制改善非酒精性脂肪肝炎(NASH)症状,被认为是极具潜力的NASH治疗药物。The structure of GFT-505 is shown in I, which has the characteristic structure of phenoxyacetic acid, and is a kind of PPAR (peroxisome proliferator-activated receptor) α/δ dual agonist. In preclinical and clinical studies, GFT-505 has shown pharmacological effects such as increasing fatty acid oxidation, improving insulin sensitivity, anti-inflammation, and anti-fibrosis; in addition, it was well tolerated in clinical trials, and no serious adverse reactions occurred. GFT-505 can improve the symptoms of non-alcoholic steatohepatitis (NASH) through multiple mechanisms, and is considered to be a promising drug for the treatment of NASH.
专利WO2004005233披露了GFT-505的合成方法,该方法将2,6-二甲基苯酚与溴代异丁酸酯在碳酸钾/乙腈中回流得到酯类中间体,再经10倍当量的三氟醋酸处理后得到GFT-505。其中,第一步烷基化反应需使用大于3倍当量的溴代异丁酸酯,反应时间长,反应结束后,苯酚中间体无法完全反应,且有大量副产物生成(如溴代异丁酸酯的消除产物),大大影响了产物的分离,需要柱层析进一步纯化;第二步脱保护反应需要使用过量三氟醋酸处理烷基化产物。Patent WO2004005233 discloses the synthesis method of GFT-505. In this method, 2,6-dimethylphenol and bromoisobutyrate are refluxed in potassium carbonate/acetonitrile to obtain ester intermediates, and then 10 times the equivalent of trifluoro GFT-505 was obtained after treatment with acetic acid. Wherein, the first step alkylation reaction needs to use greater than 3 times the equivalent of bromoisobutyrate, and the reaction time is long. After the reaction finishes, the phenol intermediate cannot react completely, and a large amount of by-products are generated (such as bromoisobutyl The elimination product of the ester), which greatly affects the separation of the product, requires further purification by column chromatography; the second step of the deprotection reaction requires the use of excess trifluoroacetic acid to treat the alkylated product.
专利US20060142611、WO2018060372及WO2018060373采用了类似的方法,对烷基化条件进行了改动,但是仍存在反应时间过长,溴代异丁酸酯需要3至9倍当量,消耗量大,使反应后处理及纯化更加复杂;此外,羧酸酯脱保护需使用过量三氟醋酸,增加废酸排放,存在环保隐患。Patents US20060142611, WO2018060372 and WO2018060373 have adopted similar methods to modify the alkylation conditions, but the reaction time is still too long, bromoisobutyrate needs 3 to 9 times the equivalent, and the consumption is large, which makes post-reaction treatment And the purification is more complicated; in addition, the deprotection of the carboxylate requires the use of excess trifluoroacetic acid, which increases the discharge of waste acid and poses environmental risks.
专利WO2019186410烷基化反应使用了溴代异丁酸乙酯,并通过碱性条件水解获得GFT-505。与上述路线类似,该制备方法同样存在反应时间长、后处理繁琐和烷基化试剂过量等问题。The alkylation reaction of patent WO2019186410 uses ethyl bromoisobutyrate, and hydrolyzes under alkaline conditions to obtain GFT-505. Similar to the above-mentioned route, this preparation method also has problems such as long reaction time, cumbersome post-treatment and excessive alkylating reagent.
上述现有技术均需经历溴代异丁酸酯烷基化与羧酸酯脱保护两步合成,路线长,且两步总收率较低,物料利用率低。The above-mentioned existing technologies all need to undergo two-step synthesis of bromoisobutyrate alkylation and carboxylate deprotection, the route is long, and the total yield of the two steps is low, and the material utilization rate is low.
专利WO2019025017改用一步制备方法,该制备方法以3,5-二甲基-4-羟基苯甲醛及4-甲硫基苯乙酮为起始原料,通过控制碱及原料的加入顺序,实现了一锅法制备GFT-505。然而,该反应过程存在原料自身缩合副产物,导致反应中间体及产物成分复杂,产率较低;此外,该制备方法后处理繁琐,纯化难度大。Patent WO2019025017 uses a one-step preparation method instead. This preparation method uses 3,5-dimethyl-4-hydroxybenzaldehyde and 4-methylthioacetophenone as starting materials, and realizes One-pot preparation of GFT-505. However, there are condensation by-products of the raw materials in the reaction process, resulting in complex reaction intermediates and product components, and low yield; in addition, the preparation method is cumbersome to process and difficult to purify.
发明内容Contents of the invention
发明目的:本发明旨在提供一种操作简捷高效、经济环保、产品总收率和纯度高的GFT-505的制备方法。Purpose of the invention: The present invention aims to provide a preparation method of GFT-505 with simple and efficient operation, economical and environmental protection, high product yield and high purity.
技术方案:本发明的苯氧乙酸类衍生物的制备方法,在碱催化下,将溶解于溶剂的(E)-2,6-二甲基-4-(3-(4-(甲硫基)苯基)-3-氧代丙-1-烯-1-基)苯酚与2-溴异丁酸进行保温反应。Technical solution: The preparation method of the phenoxyacetic acid derivatives of the present invention, under the catalysis of the base, the (E)-2,6-dimethyl-4-(3-(4-(methylthio) dissolved in the solvent ) phenyl) -3-oxoprop-1-en-1-yl) phenol and 2-bromoisobutyric acid for insulation reaction.
本发明的制备方法先将(E)-2,6-二甲基-4-(3-(4-(甲硫基)苯基)-3-氧代丙-1-烯-1-基)苯酚溶解于溶剂中,然后加入碱或者碱与溶剂的混合物,加入形式依据碱的固液状态,此步加料顺序可以倒置。此混合物再与2-溴异丁酸溶液进行反应至结束,然后经淬灭、酸化、萃取、洗涤、干燥、浓缩和纯化步骤,得到产品。In the preparation method of the present invention, (E)-2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxoprop-1-en-1-yl) Dissolve the phenol in the solvent, then add the base or the mixture of the base and the solvent, the addition form depends on the solid-liquid state of the base, and the order of addition in this step can be reversed. The mixture is then reacted with 2-bromoisobutyric acid solution to completion, and then quenched, acidified, extracted, washed, dried, concentrated and purified to obtain the product.
优选,所述碱为氢氧化钾、氢氧化钠、氢氧化锂、碳酸铯、叔丁醇钾、叔丁醇钠、叔丁醇镁、三乙胺、N,N-二异丙基乙胺、1,8-二氮杂二环十一碳-7-烯、二乙胺或二异丙胺。Preferably, the base is potassium hydroxide, sodium hydroxide, lithium hydroxide, cesium carbonate, potassium tert-butoxide, sodium tert-butoxide, magnesium tert-butoxide, triethylamine, N,N-diisopropylethylamine , 1,8-diazabicycloundec-7-ene, diethylamine or diisopropylamine.
优选,所述碱与(E)-2,6-二甲基-4-(3-(4-(甲硫基)苯基)-3-氧代丙-1-烯-1-基)苯酚的摩尔比为1:1-10:1。Preferably, the base and (E)-2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxoprop-1-en-1-yl)phenol The molar ratio is 1:1-10:1.
优选,所述溶剂为甲苯、四氢呋喃、1,4-二氧六环、乙二醇二甲醚、乙腈、N,N-二甲基甲酰胺、N,N-二甲基乙酰胺、N-甲基吡咯烷酮、二甲基亚砜、甲醇、乙醇、正丙醇、异丙醇、正丁醇、水中的一种或两种。Preferably, the solvent is toluene, tetrahydrofuran, 1,4-dioxane, ethylene glycol dimethyl ether, acetonitrile, N,N-dimethylformamide, N,N-dimethylacetamide, N- One or two of methylpyrrolidone, dimethyl sulfoxide, methanol, ethanol, n-propanol, isopropanol, n-butanol, and water.
优选,所述2-溴异丁酸与(E)-2,6-二甲基-4-(3-(4-(甲硫基)苯基)-3-氧代丙-1-烯-1-基)苯酚的摩尔比为1:1-3:1;该摩尔比进一步优选为1:1-1.5:1。Preferably, the 2-bromoisobutyric acid and (E)-2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxoprop-1-ene- The molar ratio of 1-yl)phenol is 1:1-3:1; the molar ratio is further preferably 1:1-1.5:1.
优选,所述保温反应的反应温度为20℃至120℃。Preferably, the reaction temperature of the heat preservation reaction is 20°C to 120°C.
所述制备方法制备得到的苯氧乙酸类衍生物的总收率为75%以上,纯度为99%以上。The total yield of the phenoxyacetic acid derivatives prepared by the preparation method is more than 75%, and the purity is more than 99%.
本发明的改进之处在于:首先,反应步骤仅为一步,简化了工艺路线,避免大量使用强酸和溴代试剂;其次,反应底物仅为两种,反应过程更可控,避免了反应底物之间的副反应,产物易分离纯化;最后,反应效率高,物料利用率高,苯酚中间体残留少,副产物少,后处理操作简便。The improvement of the present invention is: firstly, the reaction step is only one step, which simplifies the process route and avoids the use of strong acid and brominated reagent in large quantities; secondly, there are only two kinds of reaction substrates, and the reaction process is more controllable, avoiding the There are no side reactions between substances, and the products are easy to separate and purify; finally, the reaction efficiency is high, the material utilization rate is high, there are few residual phenol intermediates, few by-products, and the post-treatment operation is simple.
有益效果:与现有技术相比,本发明的制备方法具有如下显著优点:Beneficial effects: compared with the prior art, the preparation method of the present invention has the following significant advantages:
(1)工艺操作简捷高效,反应时间缩短,产物易分离纯化;(2)使用试剂经济环保;(3)制备所得产品的总收率高达75%以上,纯度高达99%以上。(1) The process operation is simple and efficient, the reaction time is shortened, and the product is easy to separate and purify; (2) The reagents used are economical and environmentally friendly; (3) The total yield of the prepared product is as high as 75%, and the purity is as high as 99%.
附图说明Description of drawings
图1为本发明的GFT-505的合成路线图;Fig. 1 is the synthesis roadmap of GFT-505 of the present invention;
图2为本发明的(E)-2,6-二甲基-4-(3-(4-(甲硫基)苯基)-3-氧代丙-1-烯-1-基)苯酚的1H-NMR谱图;Fig. 2 is (E)-2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxoprop-1-en-1-yl)phenol of the present invention The 1 H-NMR spectrum;
图3为本发明的GFT-505的1H-NMR谱图;Fig. 3 is the 1 H-NMR spectrogram of GFT-505 of the present invention;
图4为本发明的GFT-505的HPLC谱图。Fig. 4 is the HPLC spectrogram of GFT-505 of the present invention.
具体实施方式Detailed ways
下面结合实施例对本发明的技术方案作进一步说明。The technical solutions of the present invention will be further described below in conjunction with the embodiments.
实施例1:(E)-2,6-二甲基-4-(3-(4-(甲硫基)苯基)-3-氧代丙-1-烯-1-基)苯酚(化合物II)的制备Example 1: (E)-2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxoprop-1-en-1-yl)phenol (compound II) Preparation
在反应瓶内加入4-甲硫基苯乙酮(83g)、3,5-二甲基-4-羟基苯甲醛(75g)及乙醇(100mL),向其中加入10M氯化氢的乙醇溶液(100mL),室温搅拌过夜后,降温至0℃继续搅拌5小时。过滤烘干后,得到化合物II 137g,产率92%。1H-NMR(300MHz,CDCl3)δ7.99(d,J=8.5Hz,1H),7.76(d,J=15.6Hz,1H),7.41(d,J=15.6Hz,1H),7.37-7.30(m,4H),5.23(s,1H),2.57(s,3H),2.32(s,6H)。Add 4-methylthioacetophenone (83g), 3,5-dimethyl-4-hydroxybenzaldehyde (75g) and ethanol (100mL) in the reaction flask, add 10M hydrogen chloride ethanol solution (100mL) therein After stirring at room temperature overnight, the temperature was lowered to 0°C and stirring was continued for 5 hours. After filtration and drying, 137 g of compound II was obtained with a yield of 92%. 1 H-NMR (300MHz, CDCl 3 ) δ7.99(d, J=8.5Hz, 1H), 7.76(d, J=15.6Hz, 1H), 7.41(d, J=15.6Hz, 1H), 7.37- 7.30 (m, 4H), 5.23 (s, 1H), 2.57 (s, 3H), 2.32 (s, 6H).
实施例2:GFT-505的制备Embodiment 2: Preparation of GFT-505
在反应瓶中加入氢氧化钠(20g,0.5mol)及乙腈(100mL),搅拌同时加入化合物II(30g,0.1mol)及乙腈(200mL)的溶液;红色反应液在70℃下保温1小时。相同温度下,向反应液中滴入2-溴异丁酸(25g,0.15mol)的乙腈溶液(150mL),并通过薄层色谱(TLC)监测反应进程。反应2小时后,TLC显示化合物II反应完全。将反应液倾入200mL冰水,依次用6N盐酸酸化(pH小于3)、乙酸乙酯(500mL)萃取;有机相经饱和食盐水洗涤后干燥、浓缩,残余物乙腈重结晶,得GFT-505 31.7g,总收率82.5%,HPLC纯度99.37%(色谱柱:Agilent XDB C18,150mm×4.6mm,5.0μm;流速:1.5mL/min;流动相:水:乙腈=90:10;检测器:UV 254nm)。1H-NMR(300MHz,DMSO)δ12.90(brs,1H),8.09(d,J=8.5Hz,2H),7.81(d,J=15.6Hz,1H),7.62(d,J=15.6Hz,1H),7.56(s,2H),7.40(d,J=8.5Hz,2H),2.56(s,3H),2.23(s,6H),1.40(s,6H)。Sodium hydroxide (20g, 0.5mol) and acetonitrile (100mL) were added into the reaction flask, and a solution of compound II (30g, 0.1mol) and acetonitrile (200mL) was added while stirring; the red reaction solution was incubated at 70°C for 1 hour. At the same temperature, acetonitrile solution (150 mL) of 2-bromoisobutyric acid (25 g, 0.15 mol) was added dropwise into the reaction solution, and the reaction progress was monitored by thin layer chromatography (TLC). After reacting for 2 hours, TLC showed that compound II was completely reacted. The reaction solution was poured into 200 mL of ice water, acidified with 6N hydrochloric acid (pH less than 3), and extracted with ethyl acetate (500 mL); the organic phase was washed with saturated brine, dried, concentrated, and the residue was recrystallized from acetonitrile to obtain GFT-505 31.7g, total yield 82.5%, HPLC purity 99.37% (chromatographic column: Agilent XDB C18, 150mm×4.6mm, 5.0μm; flow rate: 1.5mL/min; mobile phase: water: acetonitrile=90:10; detector: UV 254nm). 1 H-NMR (300MHz, DMSO) δ12.90 (brs, 1H), 8.09 (d, J = 8.5Hz, 2H), 7.81 (d, J = 15.6Hz, 1H), 7.62 (d, J = 15.6Hz , 1H), 7.56(s, 2H), 7.40(d, J=8.5Hz, 2H), 2.56(s, 3H), 2.23(s, 6H), 1.40(s, 6H).
实施例3:GFT-505的制备Embodiment 3: Preparation of GFT-505
在反应瓶中,将化合物II(3g,10mmol)溶于N,N-二甲基甲酰胺(30mL),加入1,8-二氮杂二环十一碳-7-烯(15.2g,0.1mol)后在20℃下搅拌1小时。向反应液中加入2-溴异丁酸(5.01g,30mmol)的N,N-二甲基甲酰胺溶液(20mL),加毕后将反应液升温至120℃反应,并通过TLC监测反应进程。反应2小时后,TLC显示化合物II反应完全。将反应液倾入200mL冰水,依次用6N盐酸酸化(pH小于3)、乙酸乙酯(50mL×4)萃取;有机相经饱和食盐水洗涤后干燥、浓缩,残余物乙腈重结晶,得GFT-505 3.03g,总收率78.9%。In a reaction flask, compound II (3g, 10mmol) was dissolved in N,N-dimethylformamide (30mL), and 1,8-diazabicycloundec-7-ene (15.2g, 0.1 mol) and stirred at 20°C for 1 hour. Add 2-bromoisobutyric acid (5.01g, 30mmol) in N,N-dimethylformamide solution (20mL) to the reaction solution. After the addition is complete, the reaction solution is heated to 120°C for reaction, and the reaction progress is monitored by TLC . After reacting for 2 hours, TLC showed that compound II was completely reacted. The reaction solution was poured into 200 mL of ice water, acidified with 6N hydrochloric acid (pH less than 3), and extracted with ethyl acetate (50 mL×4); the organic phase was washed with saturated brine, dried and concentrated, and the residue was recrystallized from acetonitrile to obtain GFT -505 3.03g, total yield 78.9%.
实施例4:GFT-505的制备Embodiment 4: Preparation of GFT-505
在反应瓶中加入叔丁醇钾(1.12g,10mmol)、四氢呋喃(10mL)及甲苯(10mL),搅拌同时加入化合物II(3g,10mmol)与四氢呋喃(20mL)的溶液;反应液在20℃下搅拌1小时。向反应液中加入2-溴异丁酸(1.67g,10mmol)的四氢呋喃溶液(10mL),20℃下反应并通过TLC监测反应进程。反应4小时后,TLC显示化合物II反应完全。将反应液倾入20mL冰水,依次用6N盐酸酸化(pH小于3)、乙酸乙酯(100mL)萃取;有机相经饱和食盐水洗涤后干燥、浓缩,残余物乙腈重结晶,得GFT-505 3.08g,总收率80.2%。Potassium tert-butoxide (1.12g, 10mmol), tetrahydrofuran (10mL) and toluene (10mL) were added to the reaction flask, and a solution of compound II (3g, 10mmol) and tetrahydrofuran (20mL) was added while stirring; the reaction solution was heated at 20°C Stir for 1 hour. A tetrahydrofuran solution (10 mL) of 2-bromoisobutyric acid (1.67 g, 10 mmol) was added to the reaction liquid, reacted at 20° C. and monitored the reaction progress by TLC. After reacting for 4 hours, TLC showed that compound II was completely reacted. The reaction solution was poured into 20 mL of ice water, acidified with 6N hydrochloric acid (pH less than 3), and extracted with ethyl acetate (100 mL); the organic phase was washed with saturated brine, dried, concentrated, and the residue was recrystallized from acetonitrile to obtain GFT-505 3.08g, total yield 80.2%.
实施例5:GFT-505的制备Embodiment 5: Preparation of GFT-505
参照实施例3的制备方法,化合物II投料量为3g(10mmol),2-溴异丁酸投料量为5.01g(20mmol);将碱为三乙胺(3.04g,30mmol),溶剂为乙醇,反应温度保持在40℃,得GFT-505 2.96g,总收率77.1%。With reference to the preparation method of Example 3, the amount of compound II is 3g (10mmol), and the amount of 2-bromoisobutyric acid is 5.01g (20mmol); the base is triethylamine (3.04g, 30mmol), and the solvent is ethanol. The reaction temperature was maintained at 40°C to obtain 2.96g of GFT-505 with a total yield of 77.1%.
实施例6:GFT-505的制备Embodiment 6: Preparation of GFT-505
参照实施例3的制备方法,化合物II投料量为3g(10mmol),将碱为碳酸铯(26.07g,80mmol),溶剂为1,4-二氧六环,反应温度保持在80℃,得GFT-5053.07g,总收率79.9%。Referring to the preparation method of Example 3, the amount of compound II is 3g (10mmol), the base is cesium carbonate (26.07g, 80mmol), the solvent is 1,4-dioxane, and the reaction temperature is maintained at 80°C to obtain GFT -5053.07g, total yield 79.9%.
实施例7:GFT-505的制备Embodiment 7: Preparation of GFT-505
参照实施例3的制备方法,化合物II投料量为3g(10mmol),将碱更换为N,N-二异丙基乙胺(3.88g,30mmol),溶剂更换为水-二甲基亚砜混合溶剂(V水:VDMSO=1:5),反应温度保持在100℃,得GFT-505 2.92g,总收率76.0%。Referring to the preparation method of Example 3, the dosage of compound II is 3g (10mmol), the base is replaced by N,N-diisopropylethylamine (3.88g, 30mmol), the solvent is replaced by water-dimethyl sulfoxide mixture Solvent (V water : V DMSO = 1:5), and the reaction temperature was kept at 100°C to obtain 2.92g of GFT-505 with a total yield of 76.0%.
对比例1:参考US20060142611方法制备GFT-505Comparative Example 1: GFT-505 was prepared by referring to the US20060142611 method
将参照实施例1中的方法制备得到的化合物II(3.0g)加入到乙腈(20mL)中,依次加入碳酸钾(2.1g)、2-溴代异丁酸叔丁酯(1.5g),反应液在80℃反应12小时;滤除无机盐,补加碳酸钾(2.1g)、2-溴代异丁酸叔丁酯(1.5g)后80℃反应12小时;再次滤除无机盐,并第三次加入碳酸钾(2.1g)与2-溴代异丁酸叔丁酯(1.5g),80℃反应12小时。反应液过滤后浓缩,残余物经柱层析纯化(石油醚:乙酸乙酯=10:1),得黄色油状中间体III(2.7g),该步产率61.3%。所得中间体溶解于二氯甲烷(9mL)中,冰浴下滴入三氟醋酸(4.5mL),棕红色反应液室温反应12小时后浓缩干,加入甲苯后再次浓缩,残余物柱层析纯化(二氯甲烷:甲醇=20:1),得GFT-505 1.81g,该步产率76.1%。Compound II (3.0 g) prepared by the method in Example 1 was added to acetonitrile (20 mL), potassium carbonate (2.1 g), tert-butyl 2-bromoisobutyrate (1.5 g) were added successively, and the reaction Solution was reacted at 80°C for 12 hours; filtered off inorganic salts, added potassium carbonate (2.1g) and tert-butyl 2-bromoisobutyrate (1.5g) and reacted at 80°C for 12 hours; filtered off inorganic salts again, and Potassium carbonate (2.1 g) and tert-butyl 2-bromoisobutyrate (1.5 g) were added for the third time, and reacted at 80° C. for 12 hours. The reaction solution was concentrated after filtration, and the residue was purified by column chromatography (petroleum ether: ethyl acetate = 10:1) to obtain intermediate III (2.7 g) as a yellow oil, and the yield of this step was 61.3%. The obtained intermediate was dissolved in dichloromethane (9mL), and trifluoroacetic acid (4.5mL) was added dropwise under an ice bath. The brown-red reaction solution was reacted at room temperature for 12 hours and then concentrated to dryness. After adding toluene, it was concentrated again, and the residue was purified by column chromatography. (dichloromethane:methanol=20:1), 1.81 g of GFT-505 was obtained, and the yield of this step was 76.1%.
与实施例2相比,该方法缺点如下:Compared with embodiment 2, this method shortcoming is as follows:
(1)需两步合成GFT-505,总收率低,仅为46.8%;(1) GFT-505 needs to be synthesized in two steps, and the total yield is low, only 46.8%;
(2)需要反复滤除反应生成的盐,操作繁琐;(2) need to repeatedly filter out the salt that reaction generates, and operation is loaded down with trivial details;
(3)需要加三次碱及烷基化试剂,且每次烷基化反应时间较长,效率较低;(3) Alkali and alkylating agent need to be added three times, and each alkylation reaction time is longer, and the efficiency is lower;
(4)使用大量烷基化试剂及三氟醋酸,环境不友好;(4) Use a large amount of alkylating reagents and trifluoroacetic acid, which is not environmentally friendly;
(5)过量试剂导致后处理繁琐,需要柱层析纯化才能得到产物。(5) Excessive reagents lead to cumbersome post-processing, and column chromatography purification is required to obtain the product.
对比例2:参考WO2019025017方法制备GFT-505Comparative Example 2: Preparation of GFT-505 with reference to the method of WO2019025017
3,5-二甲基-4-羟基苯甲醛(300mg,2mmol)溶解于四氢呋喃(6mL)中,加入氢氧化钠(360mg,9mmol)后充分搅拌至形成黄绿色酚钠盐。悬浮液内加入正丙醇(2mL)后升温至50℃;将2-溴代异丁酸(1002mg,6mmol)与4-甲硫基苯乙酮(332mg,2mmol)溶于2mL四氢呋喃中,该混合溶液缓慢滴入上述钠盐悬浮液中,并于50℃反应2小时。向反应液内加入1M氢氧化钠溶液(10mL),反应混合液升温并将四氢呋喃蒸除;残余物加入1M盐酸。所得混合物用甲基叔丁基醚萃取后,用1M碳酸钠溶液洗涤。向混合液中加入适量氯化钠,确保终产物钠盐析出。收集钠盐再次用1M盐酸酸化,并用甲苯萃取。萃取液浓缩结晶后,得GFT-505 350mg,产率45.5%。3,5-Dimethyl-4-hydroxybenzaldehyde (300mg, 2mmol) was dissolved in tetrahydrofuran (6mL), sodium hydroxide (360mg, 9mmol) was added and stirred well until the yellow-green phenol sodium salt was formed. After adding n-propanol (2mL) to the suspension, the temperature was raised to 50°C; 2-bromoisobutyric acid (1002mg, 6mmol) and 4-methylthioacetophenone (332mg, 2mmol) were dissolved in 2mL of tetrahydrofuran. The mixed solution was slowly dropped into the above sodium salt suspension, and reacted at 50° C. for 2 hours. 1M sodium hydroxide solution (10 mL) was added to the reaction solution, the temperature of the reaction mixture was raised and THF was distilled off; the residue was added with 1M hydrochloric acid. The resulting mixture was extracted with methyl tert-butyl ether and washed with 1M sodium carbonate solution. Add an appropriate amount of sodium chloride to the mixed solution to ensure that the sodium salt of the final product is precipitated. The collected sodium salts were acidified again with 1M hydrochloric acid and extracted with toluene. After the extract was concentrated and crystallized, 350 mg of GFT-505 was obtained with a yield of 45.5%.
与实施例2相比,该方法缺点如下:Compared with embodiment 2, this method shortcoming is as follows:
(1)反应组分多,导致反应中间体较多,且碱性条件下4-甲硫基苯乙酮存在自身缩合产物,导致反应可控性降低;(1) There are many reaction components, resulting in more reaction intermediates, and there are self-condensation products in 4-methylthioacetophenone under alkaline conditions, resulting in a reduction in the controllability of the reaction;
(2)操作及后处理极为繁琐,影响反应重现性,并导致反应路线最终产率较低,不利于工艺放大;(2) The operation and post-processing are extremely cumbersome, which affects the reproducibility of the reaction, and leads to a low final yield of the reaction route, which is not conducive to process scale-up;
(3)实验规模小,未实现克级制备,可行性较低。(3) The experimental scale is small, the gram-level preparation has not been realized, and the feasibility is low.
对比例3:GFT-505的制备Comparative Example 3: Preparation of GFT-505
在反应瓶中加入碳酸钾(6.9g,50mmol)及乙腈(10mL),20℃搅拌下,加入化合物II(3g,10mmol)及乙腈(20mL);反应液在70℃下保温1小时。相同温度下,向反应液中加入2-溴异丁酸(2.5g,15mol)的乙腈溶液(15mL),并通过薄层色谱(TLC)监测反应进程。TLC显示化合物II始终存在,且无产物点生成。待反应至16小时后,将反应液倾入20mL冰水,依次用6N盐酸酸化(pH小于3)、乙酸乙酯(50mL)萃取;有机相经饱和食盐水洗涤后干燥、浓缩,残余物柱层析纯化,回收得到化合物II(2.56g),回收率85.3%。Potassium carbonate (6.9g, 50mmol) and acetonitrile (10mL) were added to the reaction flask, compound II (3g, 10mmol) and acetonitrile (20mL) were added under stirring at 20°C; the reaction solution was incubated at 70°C for 1 hour. At the same temperature, 2-bromoisobutyric acid (2.5 g, 15 mol) in acetonitrile (15 mL) was added to the reaction liquid, and the reaction progress was monitored by thin layer chromatography (TLC). TLC showed that compound II was always present, and no product spot was formed. After reacting for 16 hours, the reaction solution was poured into 20 mL of ice water, acidified with 6N hydrochloric acid (pH less than 3), and extracted with ethyl acetate (50 mL); the organic phase was washed with saturated brine, dried, concentrated, and the residue was Purified by chromatography, compound II (2.56 g) was recovered with a recovery rate of 85.3%.
结果表明,采用碳酸钾作为催化剂时,不能得到目标产物GFT-505,因此,本发明选用的催化剂是经过筛选研究确认得到的。The result shows that when potassium carbonate is used as the catalyst, the target product GFT-505 cannot be obtained. Therefore, the catalyst selected by the present invention is obtained through screening research confirmation.
对比例4:GFT-505的制备Comparative Example 4: Preparation of GFT-505
参照实施例2的制备方法,与实施例2的制备方法区别在于,化合物II投料量为30g(0.1mol)、氢氧化钠投料量为60g(1.5mol),即将氢氧化钠与化合物II的摩尔比提升至15:1,得GFT-505 20.4g,总收率53.1%。With reference to the preparation method of Example 2, the difference from the preparation method of Example 2 is that the compound II charging amount is 30g (0.1mol), and the sodium hydroxide charging amount is 60g (1.5mol), that is, the molar amount of sodium hydroxide and compound II The ratio was increased to 15:1 to obtain 20.4g of GFT-505 with a total yield of 53.1%.
与实施例2对比结果表明,提高碱的摩尔比至15:1后,由于存在大量不溶性的盐类物质,阻碍了反应物的充分接触,目标产物收率大大降低;此外,加大碱的比例后,后续中和消耗的盐酸含量增加。因此,本发明选用的碱与化合物II的摩尔比是经过筛选研究确认得到的。Compared with Example 2, the results show that after increasing the molar ratio of the alkali to 15:1, due to the presence of a large amount of insoluble salts, the full contact of the reactants is hindered, and the yield of the target product is greatly reduced; in addition, increasing the ratio of the alkali After that, the amount of hydrochloric acid consumed in the subsequent neutralization increases. Therefore, the molar ratio of the base to compound II selected in the present invention is confirmed through screening studies.
对比例5:GFT-505的制备Comparative Example 5: Preparation of GFT-505
反应瓶中加入化合物II(600mg,2mmol)及2-丁酮(5mL),室温搅拌下分批加入氢氧化钠(240mg,6mmol);反应液在50℃下保温1小时。在相同温度下,向反应液中滴入2-溴异丁酸(1002mg,6mmol)的2-丁酮溶液(4mL),滴加完毕继续反应2小时。向反应液中加入2N盐酸,调pH至酸性(pH小于3),用乙酸乙酯(5mL×3)萃取;有机相经饱和食盐水洗涤后干燥、浓缩,所得残余物经柱层析纯化(二氯甲烷:甲醇=50:1-20:1),分离得到GFT-505 55mg,总收率7.2%。Compound II (600 mg, 2 mmol) and 2-butanone (5 mL) were added to the reaction flask, and sodium hydroxide (240 mg, 6 mmol) was added in batches under stirring at room temperature; the reaction solution was incubated at 50° C. for 1 hour. At the same temperature, a solution of 2-bromoisobutyric acid (1002 mg, 6 mmol) in 2-butanone (4 mL) was added dropwise to the reaction liquid, and the reaction was continued for 2 hours after the addition was completed. 2N hydrochloric acid was added to the reaction solution to adjust the pH to acidic (pH less than 3), and extracted with ethyl acetate (5mL×3); the organic phase was washed with saturated brine, dried and concentrated, and the obtained residue was purified by column chromatography ( Dichloromethane:methanol=50:1-20:1), and 55 mg of GFT-505 was isolated with a total yield of 7.2%.
结果表明,采用2-丁酮作为反应溶剂时,目标产物收率低,因此,本发明选用的溶剂是经过筛选研究确认得到的。Result shows, when adopting 2-butanone as reaction solvent, target product yield is low, and therefore, the solvent that the present invention selects is confirmed to obtain through screening research.
对比例6:GFT-505的制备Comparative Example 6: Preparation of GFT-505
参照实施例2的制备方法,与实施例2的制备方法区别在于,化合物II投料量为30g(0.1mol)、2-溴异丁酸投料量为134g(0.8mol),即将2-溴异丁酸与化合物II的摩尔比提升至8:1,得GFT-505 17.6g,总收率45.8%。With reference to the preparation method of Example 2, the difference from the preparation method of Example 2 is that the compound II dosage is 30g (0.1mol), and the dosage of 2-bromoisobutyric acid is 134g (0.8mol), that is, 2-bromoisobutyric acid The molar ratio of acid to compound II was raised to 8:1 to obtain 17.6 g of GFT-505 with a total yield of 45.8%.
与实施例2对比结果表明,提高2-溴异丁酸的摩尔比至8:1后,由于存在大量未反应的烷基化试剂或其消除副产物,导致目标产物收率大大降低。因此,本发明选用的2-溴异丁酸与化合物II的摩尔比是经过筛选研究确认得到的。The results compared with Example 2 show that after increasing the molar ratio of 2-bromoisobutyric acid to 8:1, the yield of the target product is greatly reduced due to the presence of a large amount of unreacted alkylating agent or its elimination by-products. Therefore, the molar ratio of 2-bromoisobutyric acid to compound II selected in the present invention is confirmed through screening studies.
对比例7:GFT-505的制备Comparative Example 7: Preparation of GFT-505
参照实施例2的制备方法,与实施例2的制备方法区别在于,将加料温度与反应温度均控制在0℃,得GFT-505 16.1g,总收率41.9%。Referring to the preparation method of Example 2, the difference from the preparation method of Example 2 is that both the feeding temperature and the reaction temperature are controlled at 0° C. to obtain 16.1 g of GFT-505 with a total yield of 41.9%.
与实施例2对比结果表明,反应温度降低至0℃后,目标产物收率降低,本发明选用的反应温度是经过筛选研究确认得到的。Compared with Example 2, the results show that when the reaction temperature is lowered to 0° C., the yield of the target product decreases, and the reaction temperature selected in the present invention is confirmed through screening studies.
对比例8:GFT-505的制备Comparative Example 8: Preparation of GFT-505
参照实施例2的制备方法,与实施例2的制备方法区别在于,将溶剂更换为N,N-二甲基甲酰胺,反应温度提升至150℃,得GFT-505 23.3g,总收率60.7%。Referring to the preparation method of Example 2, the difference from the preparation method of Example 2 is that the solvent was replaced with N,N-dimethylformamide, and the reaction temperature was raised to 150°C to obtain 23.3g of GFT-505 with a total yield of 60.7 %.
与实施例2对比结果表明,反应温度升高至150℃后,目标产物收率降低,本发明选用的反应温度是经过筛选研究确认得到的。Compared with Example 2, the results show that when the reaction temperature is increased to 150° C., the yield of the target product decreases, and the reaction temperature selected in the present invention is obtained through screening and research confirmation.
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911395193.4A CN113121394B (en) | 2019-12-30 | 2019-12-30 | Preparation method of phenoxyacetic acid derivative |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911395193.4A CN113121394B (en) | 2019-12-30 | 2019-12-30 | Preparation method of phenoxyacetic acid derivative |
Publications (2)
Publication Number | Publication Date |
---|---|
CN113121394A CN113121394A (en) | 2021-07-16 |
CN113121394B true CN113121394B (en) | 2022-11-08 |
Family
ID=76767680
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911395193.4A Active CN113121394B (en) | 2019-12-30 | 2019-12-30 | Preparation method of phenoxyacetic acid derivative |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113121394B (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1071416A (en) * | 1991-09-27 | 1993-04-28 | 伊莱利利公司 | N-alkyl-3-phenyl-3-(2-alkylthiophe-noxy) propylamine |
CN1668565A (en) * | 2002-07-08 | 2005-09-14 | 基恩菲特公司 | Substituted 1,3-diphenylprop-2-en-1-one derivatives and preparation and uses thereof |
CN101522192A (en) * | 2006-07-24 | 2009-09-02 | 基恩菲特 | Substituted imidazolone derivatives, preparation and uses |
WO2019025017A1 (en) * | 2017-08-04 | 2019-02-07 | Advitech Advisory And Technologies Sa | Process for the preparation of elafibranor and novel synthesis intermediates |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2857361B1 (en) * | 2003-07-08 | 2005-09-09 | Genfit S A | PREPARATION OF 1,3-DIPHENYPROP-2-¼n-1-one DERIVATIVES |
-
2019
- 2019-12-30 CN CN201911395193.4A patent/CN113121394B/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1071416A (en) * | 1991-09-27 | 1993-04-28 | 伊莱利利公司 | N-alkyl-3-phenyl-3-(2-alkylthiophe-noxy) propylamine |
CN1668565A (en) * | 2002-07-08 | 2005-09-14 | 基恩菲特公司 | Substituted 1,3-diphenylprop-2-en-1-one derivatives and preparation and uses thereof |
CN101522192A (en) * | 2006-07-24 | 2009-09-02 | 基恩菲特 | Substituted imidazolone derivatives, preparation and uses |
WO2019025017A1 (en) * | 2017-08-04 | 2019-02-07 | Advitech Advisory And Technologies Sa | Process for the preparation of elafibranor and novel synthesis intermediates |
Non-Patent Citations (1)
Title |
---|
苯氧乙酸类化合物的合成及其降脂活性;吴洁等;《中国药科大学学报》;20021231;第33卷(第6期);478-482 * |
Also Published As
Publication number | Publication date |
---|---|
CN113121394A (en) | 2021-07-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102627573B (en) | Synthesis method for 5-aminolevulinic acid hydrochloride | |
CN103228137B (en) | The synthesis of substituted salicylaldehyde derivatives | |
WO2016145990A1 (en) | Method of preparation for ledipasvir and derivative thereof, and intermediate compound for preparation of ledipasvir | |
CN103224479B (en) | Synthetic method of 2-arylbenzofuran compounds | |
KR20120039344A (en) | A novel method of making endoxifen | |
CN113121394B (en) | Preparation method of phenoxyacetic acid derivative | |
JP4528123B2 (en) | Process for the production of nitrooxy derivatives of naproxen | |
CN105061230A (en) | Method for preparing dapoxetine hydrochloride | |
JP2002326992A (en) | N-spiro asymmetric phase transfer catalyst containing binaphthayl group and biphenyl group | |
EP3728167B1 (en) | A process for the preparation of crisaborole | |
CN106916116A (en) | It is a kind of to contain α, the environment-friendly preparation method of the 1 of beta unsaturated ketone, 2,4 oxadiazole class compounds in high yield | |
CN108047258B (en) | Method for synthesizing aminopyridine borate | |
CN103450092B (en) | Synthesis method of metronidazole-sulfanilamide derivatives | |
CN104276999A (en) | Preparation method and intermediate of 3-hydroxyl-5-aryl pyridine-2-formamide derivative | |
CN113045463B (en) | Synthesis method of (E) -3-arylthio-2-iodoethyl acrylate compound | |
CN109553649B (en) | A kind of preparation method of canagliflozin intermediate | |
WO2021229244A1 (en) | Process for the synthesis of n-butyloxycarbonyl-3-(4-imidazol-1-ylmethylphenyl)-5-iso-butylthiophene-2-sulfonamide | |
CN107522615A (en) | Synthesis method of beta-iodoformate compound | |
CN109593068B (en) | Intermediate of ROR gamma inhibitor and preparation method thereof | |
WO2017152539A1 (en) | 4-sulfur pentafluoride phenol compound and preparation method therefor, and preparation method for sulfur pentafluoride substituted benzopyran compound | |
CN113336780B (en) | Preparation method of 2-formyl-4- (4-cyanophenoxy) phenylboronic acid pinacol ester | |
CN105503762A (en) | Method for preparing 5-aminotetrazole compound | |
JP2003212861A (en) | Method for producing pyrimidinyl alcohol derivative and synthetic intermediate thereof | |
CN111072638A (en) | Method for preparing AZD4547, intermediate and preparation method of intermediate | |
US20140303402A1 (en) | Process for the preparation of sulfonamide compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |